CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells

Commun Biol. 2020 Jul 14;3(1):375. doi: 10.1038/s42003-020-1097-8.

Abstract

Regulatory T cells (Tregs) are critical mediators of immune homeostasis. The co-stimulatory molecule CD27 is a marker of highly suppressive Tregs, although the role of the CD27-CD70 receptor-ligand interaction in Tregs is not clear. Here we show that after prolonged in vitro stimulation, a significant proportion of human Tregs gain stable CD70 expression while losing CD27. The expression of CD70 in expanded Tregs is associated with a profound loss of regulatory function and an unusual ability to provide CD70-directed co-stimulation to TCR-activated conventional T cells. Genetic deletion of CD70 or its blockade prevents Tregs from delivering this co-stimulatory signal, thus maintaining their regulatory activity. High resolution targeted single-cell RNA sequencing of human peripheral blood confirms the presence of CD27-CD70+ Treg cells. These findings have important implications for Treg-based clinical studies where cells are expanded over extended periods in order to achieve sufficient treatment doses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD27 Ligand / genetics
  • CD27 Ligand / metabolism*
  • CRISPR-Associated Protein 9
  • CRISPR-Cas Systems
  • Female
  • Flow Cytometry
  • Forkhead Transcription Factors / metabolism
  • Gene Editing
  • Gene Knockout Techniques
  • Humans
  • Mice, Inbred BALB C
  • Sequence Analysis, RNA
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / metabolism
  • T-Lymphocytes, Regulatory / transplantation
  • Transcriptome
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / metabolism

Substances

  • CD27 Ligand
  • CD70 protein, human
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
  • CRISPR-Associated Protein 9